Reuters logo
BRIEF-United Therapeutics announces regulatory delays for Remosynch Implantable Pump
April 3, 2017 / 10:10 AM / 8 months ago

BRIEF-United Therapeutics announces regulatory delays for Remosynch Implantable Pump

April 3 (Reuters) - United Therapeutics Corp:

* United Therapeutics-regulatory delays will result in postponement of planned U.S. launch of remosynch implantable system for remodulin until 2018

* United therapeutics - in order to launch remosynch in U.S, medtronic and co have been pursuing parallel regulatory filings relating to device and drug Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below